薩瑞普塔治療公司（NASDAQ:SRPT）報告季度收益爲每股$1.90，與分析師的共識預期一致。相比去年同期每股收益$0.82，增長了131.71%。公司報告的季度銷售額爲$6.58412億，高出分析師預期的$6.27582億，增幅達4.91%。與去年同期銷售額$3.96781億相比，這一銷售額增加了65.94%。

以上內容來自Benzinga Earnings專欄，原文如下：

Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $1.90 per share which met the analyst consensus estimate. This is a 131.71 percent increase over earnings of $0.82 per share from the same period last year. The company reported quarterly sales of $658.412 million which beat the analyst consensus estimate of $627.582 million by 4.91 percent. This is a 65.94 percent increase over sales of $396.781 million the same period last year.